OH-PROAMPAC
1.5.2023 16:18:28 CEST | Business Wire | Press release
ProAmpac, a leader in flexible packaging and material science, will showcase its products at Interpack, a worldwide exhibition for the packaging industry, in Hall 10, Stand D21. The event is scheduled to take place in Dusseldorf, Germany, from 4-10 May.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230501005442/en/
ProActive Recyclable R-2050 is a high-performance mono PE recyclable film that features superior heat resistance, excellent directional tear for easy opening and various barrier properties available to suit even the most sensitive products. (Photo: Business Wire)
"We're thrilled to be back at Interpack this year with sustainable packaging innovation and our expanded capabilities in Europe, Ireland, and the UK. Our recent additions, such as digital printing, spouted and aseptic pouching, and our commitment to ESG goals, enable us to collaborate on the latest innovations in flexible packaging," states Adam Grose, chief commercial officer for ProAmpac.
Sustainable Packaging Innovations
ProAmpac will showcase its sustainable offerings with its ProActive Sustainability® line of packaging. New product innovations on display include:
- ProActive Recyclable R-2050. This high-performance mono PE recyclable film features superior heat resistance, excellent directional tear for easy opening and various barrier properties available to suit even the most sensitive products.
- QUADLFEX Recyclable is a film-based quad packaging solution that is perfect for high-speed filling lines. This packaging can be customized with clear windows and surface finishes and is preapproved for recycling through the in-store drop-off program.
- ProActive Recyclable RP-1000, a recyclable paper-based product that provides barrier protection for dry and non-greasy food products.
- PRO-EVO Recyclable provides excellent grease and edge-wicking resistance without intentionally adding per- and poly-fluoroalkyl substances (PFAS). PRO-EVO Recyclable is also available with a high moisture barrier to maintain the freshness of pet foods.
- RAP Packaging Products keeps food to-go fresh and offers an elevated appearance in either a hot cabinet or a chiller. Also, by weight, the largest packaging component is paperboard and paper sourced from well-managed forests, which is widely recyclable in fibre streams. ProAmpac’s food to-go packaging solutions are 2023 OPRL 90/10 compliant.
- ProActive PIR film contains 30% polyethylene-based postindustrial recycled content, meets UK Plastic Packaging Tax guidelines for tax exemption and is OPRL compliant for front-of-store drop-off. All virgin material and film used to produce ProActive PIR film are EU food contact grade materials, which comply with Regulation (EU) No 10/2011 and have also undergone additional NIAS testing.
Thought Leadership
On Monday, 8 May, at 11:00 am, Sal Pellingra, the vice president of global package design, applications, and business development at ProAmpac, will be presenting ProAmpac's Approach to Sustainability at the Interpack TV Stage, situated between Halls 7 and 9 at the North Entrance. During the presentation, Sal will highlight sustainable market trends and ProAmpac’s collaborative approach to commercialization of new ProActive Sustainability® technologies toward a more circular economy.
To set up a meeting during the show or learn how ProAmpac’s team can help you, please contact Events@ProAmpac.com or visit ProAmpac.com.
About ProAmpac
ProAmpac is a leading global flexible packaging company with a comprehensive product offering, providing creative packaging solutions, industry-leading customer service and award-winning innovation to a diverse global marketplace. ProAmpac’s approach to sustainability – ProActive Sustainability® – provides innovative sustainable flexible packaging products to help our customers achieve their sustainability goals. We are guided in our work by five core values that are the basis for our success: Integrity, Intensity, Innovation, Involvement and Impact. Cincinnati-based ProAmpac is owned by Pritzker Private Capital along with management and co-investors. For more information, visit ProAmpac.com or contact Media@ProAmpac.com.
About Pritzker Private Capital
Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products and services sectors. The firm's differentiated, long duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur- and family-owned companies. Pritzker Private Capital is a signatory to the United Nations Principles for Responsible Investment (PRI). For more information, visit PPCPartners.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230501005442/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release
A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom